---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-044136"
form_type: "8-K/A"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2024-05-16T23:59:59+00:00"
generated_at: "2026-06-01T19:59:28.028439+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Heart Test Laboratories files 8-K/A to clarify reverse stock split and warrant adjustments

## Summary
- Heart Test Laboratories filed Amendment No. 1 to Form 8-K to clarify details of its 1-for-100 reverse stock split.
- The reverse stock split affects both common stock and warrants, with split-adjusted trading expected at market open on May 17, 2024.
- The exercise price of public warrants will be proportionately increased to $425.00 per share post-split.
- The CUSIP for common stock changes to 42254E302; trading symbols HSCS and HSCSW remain unchanged.
- Equitable adjustments to outstanding warrants ensure every 100 pre-split shares become 1 post-split share upon exercise.

## SEC filing metadata
- accession: 0001213900-24-044136
- form_type: 8-K/A
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2024-05-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.03, 5.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000121390024044136/0001213900-24-044136-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000121390024044136/ea0206327-8ka1_heart.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-044136
- JSON: https://secwatch.observer/filing/0001213900-24-044136.json
- Plain text: https://secwatch.observer/filing/0001213900-24-044136.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.